Medical News

RSS

IPAB continues to draw repeal talk

Health exchanges, accountable care organizations, high-risk pools and waivers are among health law hot topics also attracting headlines.

18 Jul 2011

Disrupting protein components kills mosquitoes

Mosquitoes die soon after a blood meal if certain protein components are experimentally disrupted, a team of biochemists at the University of Arizona has discovered.

18 Jul 2011

Medicaid 'vulnerable' in deficit talks

The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.

18 Jul 2011

Brief, intense running doesn't alter kinematics and shock absorption

In competitive runners, a brief, high-intensity run doesn't cause the same kinds of fatigue-related changes in running kinematics and shock absorption as longer training runs, reports a recent issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

18 Jul 2011

Minorities get help accessing mental health care

Summer Blast, held July 9, addressed a key challenge — getting minorities to seek treatment for mental illness. So important is the issue that in 2008 the U.S. House of Representatives designated July as National Minority Mental Health Month, thanks in part to the efforts of author Bebe Moore Campbell, an advocate for greater mental health awareness among minority communities.

18 Jul 2011

Shionogi to acquire Victory Pharma's products to treat pain and infectious diseases

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced that it has entered into an agreement to acquire all currently marketed products from Victory Pharma, Inc., including seven treatments for pain and two for infectious diseases. The products, which are all approved by the Food and Drug Administration (FDA), will be marketed by Shionogi's existing sales force.

18 Jul 2011

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Upsher-Smith Laboratories, Inc. announced today the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).

18 Jul 2011

Facts and myths about bed bugs

Bed bugs are back. Since 2000, bed bug infestations have risen 81 percent, according to The National Pest Management Association. This resurgence has consumers nationwide on high alert, seeking information on the pests and how they can protect themselves.

18 Jul 2011

Thermo Fisher Scientific announces acquisition of TREK Diagnostic Systems

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired TREK Diagnostic Systems, a global provider of microbiology solutions, including blood culture, microorganism identification and antibiotic susceptibility testing (AST) products, from Magellan Biosciences. Based near Cleveland, Ohio, the company had full year revenue in 2010 of $34 million and has 150 employees.

From Thermo Fisher Scientific Inc. 18 Jul 2011

States grapple with reduced federal Medicaid match

Stateline looks at the effect to states of the loss of extra federal matching funds for Medicaid. In addition, other news outlets explore the difficulty of finding physicians who accept Medicaid patients, a financial analysis of cuts in Medicaid funding being considered as part of the debt talks in Washington and the fight in Florida over moving enrollees to a managed care style plan.

18 Jul 2011

WebMD anticipates 15% increase in revenue for second quarter 2011

WebMD Health Corp., the leading source of health information, today announced preliminary financial results for the three months ended June 30, 2011 and updated financial guidance for 2011.

18 Jul 2011

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced the formation of a majority owned subsidiary, NSVascular, Inc. and the signing of an exclusive license with the University of California, Los Angeles (UCLA) covering its medical applications of Thin-Film Nitinol (TFN) technology. Nitinol is a superelastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.

18 Jul 2011

Cardinal Health opens The Center for the Advancement of Molecular Imaging in Phoenix

Today in Phoenix, Cardinal Health opened The Center for the Advancement of Molecular Imaging – a new, first-of-its-kind collaboration laboratory that will expedite the development of nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders.

18 Jul 2011

Bacterin forays into medical devices with acquisition of Robinson MedSurg

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, has acquired the assets of Robinson MedSurg LLC (RMS), a medical device distribution company focused primarily on maxillofacial and craniofacial surgery devices.

18 Jul 2011

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

Endologix, Inc., developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc., provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe.

18 Jul 2011

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.

18 Jul 2011

Sodexo selects Xenex as preferred partner for disinfection of client facilities

Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.

18 Jul 2011

Panel discussion on global perspective of women and Alzheimer's held at AAIC 2011

Today the Alzheimer's Association® in conjunction with GE Healthcare held a "Women and Alzheimer's: A Global Perspective" panel discussion during the Alzheimer's Association International Conference 2011 (AAIC). The event brought together leaders in the Alzheimer's field and revealed new data from a survey commissioned by Alzheimer Europe.

18 Jul 2011

Drummond Group provides complete EMR certification for Varian's ARIA software for radiation oncology

Varian Medical Systems today announced its ARIA® software for electronic medical records (EMR) and clinical practice management in radiation oncology has been certified for clinics that can now use it to qualify for federal funding under the U.S. HITECH Act.

18 Jul 2011

LabCorp extends expiration of tender offer for Orchid Cellmark common stock

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 5:00 p.m., New York City time, on August 12, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc.

18 Jul 2011

Medical News

IPAB continues to draw repeal talk

Disrupting protein components kills mosquitoes

Medicaid 'vulnerable' in deficit talks

Brief, intense running doesn't alter kinematics and shock absorption

Minorities get help accessing mental health care

Shionogi to acquire Victory Pharma's products to treat pain and infectious diseases

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Facts and myths about bed bugs

Thermo Fisher Scientific announces acquisition of TREK Diagnostic Systems

States grapple with reduced federal Medicaid match

WebMD anticipates 15% increase in revenue for second quarter 2011

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

Cardinal Health opens The Center for the Advancement of Molecular Imaging in Phoenix

Bacterin forays into medical devices with acquisition of Robinson MedSurg

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Sodexo selects Xenex as preferred partner for disinfection of client facilities

Panel discussion on global perspective of women and Alzheimer's held at AAIC 2011

Drummond Group provides complete EMR certification for Varian's ARIA software for radiation oncology

LabCorp extends expiration of tender offer for Orchid Cellmark common stock

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News